Khalili Leila, Dehghan Gholamreza, Fazli Arezou, Khataee Alireza
Department of Biology, Faculty of Natural Sciences, University of Tabriz, 51666-16471 Tabriz, Iran.
Department of Biology, Faculty of Natural Sciences, University of Tabriz, 51666-16471 Tabriz, Iran.
Adv Colloid Interface Sci. 2023 Apr;314:102869. doi: 10.1016/j.cis.2023.102869. Epub 2023 Mar 5.
Over the years, layered double hydroxides (LDHs) hold a specific position in biomedicine due to their tunable chemical composition and appropriate structural properties. However, LDHs lack adequate sensitivity for active targeting because of less active surface area and low mechanical strength in physiological conditions. The exploitation of eco-friendly materials, such as chitosan (CS), for surface engineering of LDHs, whose payloads are transferred only under certain conditions, can help develop stimuli-responsive materials owing to high biosafety and unique mechanical strength. We aim to render a well-oriented scenario toward the latest achievements of a bottom-up technology relying on the surface functionalization of LDHs to fabricate functional formulations with promoted bio-functionality and high encapsulation efficiency for various bioactives. Many efforts have been devoted to critical aspects of LDHs, including systemic biosafety and the suitability for developing multicomponent systems via integration with therapeutic modalities, which are thoroughly discussed herein. In addition, a comprehensive discussion was provided for the recent progress in the emergence of CS-coated LDHs. Finally, the challenges and future perspectives in the fabrication of efficient CS-LDHs in biomedicine are considered, with a special focus on cancer treatment.
多年来,层状双氢氧化物(LDHs)因其可调节的化学成分和适当的结构特性在生物医学中占据特殊地位。然而,由于生理条件下活性表面积较小和机械强度较低,LDHs缺乏足够的主动靶向敏感性。利用壳聚糖(CS)等环保材料对LDHs进行表面工程改造,其负载仅在特定条件下转移,由于高生物安全性和独特的机械强度,有助于开发刺激响应材料。我们旨在针对一种自下而上技术的最新成果呈现一个条理清晰的方案,该技术依赖于LDHs的表面功能化来制备具有增强生物功能和对各种生物活性物质高封装效率的功能制剂。许多努力都集中在LDHs的关键方面,包括系统生物安全性以及通过与治疗方式整合来开发多组分系统的适用性,本文将对此进行全面讨论。此外,还对CS包覆LDHs出现的最新进展进行了全面讨论。最后,考虑了生物医学中高效CS-LDHs制备面临的挑战和未来前景,特别关注癌症治疗。